Relationship between disease activity index and sleep disorders in children with inflammatory bowel diseases

Dilsat Gundogdu1, Nafiye Urgancı2, Merve Usta3

  • 1Pediatrics, SBU Sisli Hamidiye Etfal Training and Research Hospital, MD, Istanbul, Turkey.

PubMed

Insights

Pediatric patients with inflammatory bowel disease (IBD) experience significant sleep disturbances, strongly linked to disease activity. The Pittsburgh Sleep Quality Index (PSQI) and disease activity indices effectively predict sleep disorders in these children.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Sleep Medicine

Background:

  • Sleep disturbances are a frequent complaint among pediatric patients diagnosed with inflammatory bowel disease (IBD), persisting even during periods of clinical remission.
  • The Pittsburgh Sleep Quality Index (PSQI) is a validated tool for assessing subjective sleep quality in various patient populations.

Purpose of the Study:

  • To determine the prevalence of sleep disturbances in pediatric IBD patients.
  • To investigate the association between IBD clinical features, disease activity, inflammatory markers, and sleep quality.
  • To evaluate the predictive value of disease activity indices for sleep disturbances in pediatric IBD.

Main Methods:

  • Retrospective analysis of clinical and demographic data, laboratory parameters, and disease activity from 99 pediatric IBD patients (44 Crohn's disease, 55 Ulcerative Colitis) and 80 healthy controls.
  • Administration of the Pittsburgh Sleep Quality Index (PSQI) to all participants.
  • Correlation analysis between PSQI scores and clinical/laboratory parameters, including disease activity indices (Pediatric Crohn's Disease Activity Index and Pediatric Ulcerative Colitis Activity Index).

Main Results:

  • Pediatric IBD patients exhibited significantly higher PSQI scores compared to healthy controls, indicating poorer sleep quality.
  • Patients with IBD, particularly those with Ulcerative Colitis, reported later sleep times and shorter sleep durations than controls.
  • Strong positive correlations were observed between disease activity indices, abdominal pain, and PSQI scores in both Crohn's disease and Ulcerative Colitis patients.
  • The Pediatric Crohn's Disease Activity Index and Pediatric Ulcerative Colitis Activity Index were identified as independent risk factors for sleep disturbances, demonstrating high sensitivity and specificity.

Conclusions:

  • Increased disease activity in pediatric IBD significantly impairs sleep quality.
  • The PSQI and specific pediatric disease activity indices (PCDAI, PUCAI) are robust tools for identifying and predicting sleep disorders in pediatric IBD patients.
  • These findings underscore the importance of assessing sleep quality in the comprehensive management of pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
299
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
357
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
489
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
223
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
198
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
155